Definitive Contract 75A50120C00096

This $48,927,887 definitive cost-type contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to the Mayo Clinic to facilitate the use of human convalescent plasma to treat hospitalized COVID-19 patients. The contract was awarded on May 1, 2020 under a Broad Agency Announcement seeking proposals for the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear and pandemic influenza threats. There was no set-aside designation for this award. Mayo Clinic, a large non-profit academic medical center, has extensive experience supporting federal agencies through prime contracts and grants, including providing services for the National Cancer Institute's Experimental Therapeutics program and diagnostic testing for the Defense Health Agency.